5 Followers on Owler
OverviewCompetitorsFundingNews & Insights

KinDex Therapeutics Competitors or Alternatives

KinDex Therapeutics's top competitors include NexImmune, Aura and Centrose.

Unlock 32 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

KinDex Therapeutics's company profile

Jeffrey Bland

President & CEO

80/100
1 - 25
$7.5M
$5M - 25M
  • $7.5M
    $5M - 25M
  • 1 - 25
    $7.5M
  • $5M - 25M
  • 80/100
  • 1 - 25
  • $7.5M
  • $5M - 25M
View ProfileView
1
KinDex Therapeutics's Competitor - NexImmune logo

Kristi Jones

CEO

86/100
70
$166.4M
  • $166.4M
  • 70
    $166.4M
  • 86/100
  • 70
  • $166.4M
View ProfileView
2
KinDex Therapeutics's Competitor - Aura logo

Natalie Holles

President & CEO

- -
50
$751.4M
  • $751.4M
  • 50
    $751.4M
  • - -
  • 50
  • $751.4M
View ProfileView
3
KinDex Therapeutics's Competitor - Centrose logo

James R. Prudent

President & CEO

90/100
1 - 25
$4.7M
$5M - 25M
  • $4.7M
    $5M - 25M
  • 1 - 25
    $4.7M
  • $5M - 25M
  • 90/100
  • 1 - 25
  • $4.7M
  • $5M - 25M
View ProfileView
4
KinDex Therapeutics's Competitor - bluebird bio logo

Andrew Obenshain

CEO

73/100
248
$821.4M
$103.9M
  • $821.4M
    $103.9M
  • 248
    $821.4M
  • $103.9M
  • 73/100
  • 248
  • $821.4M
  • $103.9M
View ProfileView
5
KinDex Therapeutics's Competitor - Perthera logo

Donna Tuths

President & CEO

82/100
25 - 100
$17.9M
$100K - 5M
  • $17.9M
    $100K - 5M
  • 25 - 100
    $17.9M
  • $100K - 5M
  • 82/100
  • 25 - 100
  • $17.9M
  • $100K - 5M
View ProfileView
KinDex Therapeutics' top 35 competitors are NexImmune, Aura, Centrose, Juno Therapeutics, bluebird bio, Perthera, Mustang Bio, Adaptimmune, Bristol-Myers Squibb, ImmunityBio, Novartis, Fate Therapeutics, UroGen, Gilead Sciences, CG Oncology, Sesen Bio, Oncodrone, Immatics, FerGene, Iovance, TScan, Tmunity, Atara, Dynavax, Marker Therapeutics, Castle Biosciences, SQZ Biotech, Amgen, Emtora Biosciences, BioNTech, VelosBio, Moderna, Elstar Therapeutics, Johnson & Johnson and Cedilla. Together they have raised over 69.0B between their estimated 325.1K employees. KinDex Therapeutics's revenue is the ranked 20th among it's top 10 competitors. The top 10 competitors average 8.4B. KinDex Therapeutics has 10 employees and is ranked 35th among it's top 10 competitors. The top 10 competitors average 9,288.

KinDex Therapeutics VS NexImmune

NexImmune is seen as one of KinDex Therapeutics's top competitors. NexImmune was founded in 2011, and is headquartered in Gaithersburg, Maryland. Like KinDex Therapeutics, NexImmune also competes in the Pharmaceuticals & Biotechnology industry. NexImmune generates $ less revenue vs. KinDex Therapeutics.

KinDex Therapeutics VS Aura

Aura is a top competitor of KinDex Therapeutics. Aura was founded in 2009, and its headquarters is in Boston, Massachusetts. Like KinDex Therapeutics, Aura also competes in the Pharmaceuticals & Biotechnology field. Aura has 40 more employees than KinDex Therapeutics.

KinDex Therapeutics VS Centrose

Centrose is KinDex Therapeutics's #3 rival. Centrose was founded in Middleton, Wisconsin} in 2007. Like KinDex Therapeutics, Centrose also works within the Pharmaceuticals industry. Compared to KinDex Therapeutics, Centrose generates $3.5M less revenue.

Looking for similar companies to KinDex Therapeutics?

Similar Companies

Pharmaceuticals companies in Seattle

See 46 companies 
Pharmaceuticals & Biotechnology companies in Seattle

See 194 companies 
Pharmaceuticals companies in Washington

See 188 companies 
Pharmaceuticals companies in Seattle Metropolitan Area

See 102 companies 
Pharmaceuticals & Biotechnology companies in Seattle Metropolitan Area

See 328 companies 
Pharmaceuticals & Biotechnology companies in Washington

See 510 companies 
Companies in Seattle with employees in 1-25 range

See 2,021 companies 
Pharmaceuticals companies with employees in 1-25 range

See 2,177 companies 
Pharmaceuticals companies with revenue in $5.0-25M range

See 2,470 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for KinDex Therapeutics and KinDex Therapeutics's Competitors

September 11, 2026BioSpace
Novartis' shares fell 13% this week after the report of three separate late-stage asset setbacks. The impact went beyond the Swiss drugmaker, dragging ...
September 11, 2026Yahoo
On August 13, a federal appeals court ruled in favor of Gilead Sciences, Inc. (NASDAQ: GILD ), upholding a preliminary injunction that bars the defenda...
September 11, 2026Benzinga
Artisan Partners calls on Novartis to revamp board governance and acquisition oversight following sharp stock declines after trial setbacks.read more...
September 11, 2026STAT News
Novartis investors are stepping up scrutiny of the company's dealmaking after setbacks to drugs it acquired through mergers and acquisitions...

Frequently Asked Questions about KinDex Therapeutics

  1. Who are KinDex Therapeutics's top competitors?

    KinDex Therapeutics's top 3 competitors are NexImmune, Aura, Centrose.

  2. Who is similar to KinDex Therapeutics?

    NexImmune is the most similar to KinDex Therapeutics. Aura and Centrose are also similar to KinDex Therapeutics.

  1. Are KinDex Therapeutics and NexImmune competitors?

    Yes, NexImmune is one of KinDex Therapeutics’s top competitors.